Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction [Phase 2]
Phase 2 clinical trial results assessing efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after my…
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure [NA]
Completed clinical trial evaluating an algorithm using LINQ sensors for evaluation and treatment of heart failure; results posted.
-
FDA approval · 2026-08-20FDA Approved: LISINOPRIL — Original Application (ANNORA PHARMA)
FDA approval overview for lisinopril original application by Annora Pharma.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: Randomized Trial of Nordic Walking vs. Standard Cardiac Rehabilitation in Patients With Heart Failure [NA]
A randomized trial comparing Nordic Walking to standard cardiac rehabilitation in heart failure patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2 [Phase 4]
Phase 4 trial results exploring mechanisms of hypotensive response to ARB/NEP inhibition in heart failure patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea [NA]
Post-market surveillance clinical trial results for the HeartMate 3 left ventricular assist system conducted in Korea, completed with result…
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Results: Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure
Clinical trial results from post-marketing surveillance of Jardiance in Korean patients with chronic heart failure have been completed and r…
-
FDA approval · 2026-07-23FDA Approved: FUROSCIX — Supplemental Application (scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation)
Supplemental application for FUROSCIX (furosemide injection 80 mg/10 mL) seeking approval for a new or expanded indication or formulation.
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Crome/Cobalt Respiration Study
A completed clinical trial (NCT06089694) sponsored by Medtronic Cardiac Rhythm and Heart Failure investigating Crome/Cobalt Respiration in h…
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Results: Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral [NA]
Completed clinical trial evaluating a social risk score, a clinical decision support tool, and closed-loop referral for social risk screenin…
-
EMA approval · 2026-07-14EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
EMA has authorized Qaialdo, a spironolactone product by Lipomed GmbH, for several conditions including edema, heart failure, liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) [Phase 4]
Phase 4 trial results evaluating dapagliflozin on cardiovascular events in acute heart failure, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure [Phase 1, Phase 2]
A crossover pharmacokinetics study comparing subcutaneous versus intravenous administration of a novel furosemide regimen in adults with chr…
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
Pilot study results explore an NTproBNP-guided strategy to cardioprotection during chemotherapy in patients with cardiotoxicity risks.
-
EMA approval · 2026-06-11EMA Authorised: Forxiga (dapagliflozin propanediol monohydrate) — AstraZeneca AB
Forxiga (dapagliflozin propanediol monohydrate) has been authorised for use in the European Medicines Agency, with indications including Typ…
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: LINK-HF2 - Remote Monitoring Analytics in Heart Failure [NA]
Completed clinical trial results for LINK-HF2 evaluating remote monitoring analytics in heart failure; results posted in 2026.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) [NA]
A completed Mayo Clinic trial (iCARE) evaluated mobile case management to improve cardiac rehabilitation outcomes.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function [Phase 3]
Phase 3 trial evaluating Balcinrenone and Dapagliflozin in patients with heart failure and impaired kidney function is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) [NA]
Clinical trial results for iCARE trial evaluating mobile case management to improve cardiac rehabilitation outcomes in patients with acute m…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands [Phase 4]
A Phase 4 trial evaluating digoxin in outpatients with chronic heart failure has completed in the Netherlands.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs [Phase 4]
A phase 4 crossover trial comparing immediate-release versus extended-release torsemide on natriuretic effects over 12 hours was withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: DuoCor Ventricular Assist System Early Feasibility Study [NA]
Update on the early feasibility trial of the DuoCor Ventricular Assist System for heart failure; the study sponsored by Shenzhen Core Medica…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure [Phase 1]
Phase 1 clinical trial assessing safety and efficacy of a novel patch infusor device combined with a subcutaneous furosemide formulation in …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating the Feasibility of Prehospital Lung Ultrasound [NA]
This clinical trial update notes a feasibility study on prehospital lung ultrasound led by Rutgers and indicates the study is not yet recrui…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Left Bundle Branch Area Pacing (LBBAP) PMCF Study [NA]
Clinical trial update from Abbott Medical Devices on a PMCF study evaluating Left Bundle Branch Area Pacing (LBBAP) for bradycardia and rela…